Mesoporous silica- and silicon-based materials ... - Helda - Helsinki.fi

Chang, J.-S., Chang, K.L.B., Hwang, D.-F., Kong, Z.-L., 2007. In vitro cytotoxicitiy of silica
nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell
line. Environ. Sci. Technol. 41, 2064-2068.
Charnay, C., Bégu, S., Tourné-Péteilh, C., Nicole, L., Lerner, D.A., Devoisselle, J.M., 2004.
Inclusion of ibuprofen in mesoporous templated silica: Drug loading and release property. Eur. J.
Pharm. Biopharm. 57, 533–540.
Chen, M., von Mikecz, A., 2005. Formation of nucleoplasmic protein aggregates impairs nuclear
function in response to SiO2 nanoparticles. Exp. Cell Res. 305, 51-62.
Chen, X., Vaughn, J.M., Yacaman, M.J., Williams, R.O., Johnston, K.P., 2004. Rapid dissolution
of high-potency danazol particles produced by evaporative precipitation into aqueous solution. J.
Pharm. Sci. 93, 1867-1878.
Chiappini, C., Tasciotti, E., Serda, R.E., Brousseau, L., Liu, X., Ferrari, M., 2011. Mesoporous
silicon particles as intravascular drug delivery vectors: Fabrication, in-vitro, and in-vivo
assessments. Phys. Status Solidi C 8, n/a. doi: 10.1002/pssc.201000344.
Chiou, W.L., Riegelman, S., 1971. Pharmaceutical applications of solid dispersion systems. J.
Pharm. Sci. 60, 1281-1302.
Choi, J., Zhang, Q., Reipa, V., Wang, N.S., Stratmeyer, M.E., Hitchins, V.M., Goering, P.L., 2009.
Comparison of cytotoxic and inflammatory responses of photoluminescent silicon nanoparticles
with silicon micron-sized particles in RAW 264.7 macrophages. J Appl. Toxicol. 29, 52-60.
Chung, T.-H., Wu, S.-H., Yao, M., Lu, C.-W., Lin, Y.-S., Hung, Y., Mou, C.-Y., Chen, Y.-C.,
Huang, D.-M., 2007. The effect of surface charge on the uptake and biological function of
mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials
28, 2959-2966.
Contessotto, L., Ghedini, E., Pinna, F., Signoretto, M., Cerrato, G., Crocellà, V., 2009. Hybrid
organic-inorganic silica gel carriers with controlled drug-delivery properties. Chem. Eur. J. 15,
12043-12049.
Crowley, M.M., Zhang, F., Repka, M.A., Thumma, S., Upadhye, S.B., Battu, S.K., McGinity,
J.W., Martin, C., 2007. Pharmaceutical applications of hot-melt extrusion: Part I. Drug Dev. Ind.
Pharm. 33, 909-926.
Dahan, A., Miller, J.M., Amidon, G.L., 2009. Prediction of solubility and permeability class
membership: Provisional BCS classification of the world’s top oral drugs. AAPS J. 11, 740-746.
DeSesso, J.M., Jacobson, C.F., 2001. Anatomical and physiological parameters affecting
gastrointestinal absorption in humans and rats. Food Chem. Toxicol. 39, 209-228.
Doadrio, J.C., Sousa, E.M.B., Izquierdo-Barba, I., Doadrio, A.L., Perez-Pariente, J., Vallet-Regí,
M., 2006. Functionalization of mesoporous materials with long alkyl chains as a strategy for
controlling drug delivery pattern. J. Mater. Chem. 16, 462-466.
Doshi, J., Reneker, D.H., 1995. Electrospinning process and applications of electrospun fibers. J.
Electrostat. 35, 151-160.
48